David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$397M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$342M |
| 3 |
Bank of America
BAC
|
+$322M |
| 4 |
Citigroup
C
|
+$260M |
| 5 |
Booking.com
BKNG
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$637M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$397M |
| 3 |
Gilead Sciences
GILD
|
+$358M |
| 4 |
Phillips 66
PSX
|
+$330M |
| 5 |
Apple
AAPL
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.78% |
| 2 | Technology | 11.11% |
| 3 | Financials | 10% |
| 4 | Consumer Discretionary | 8.83% |
| 5 | Communication Services | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LTS
3076
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
| $247K | ﹤0.01% |
98,813
+31,262
| +46% | +$73.5K |
|
3077
Gorman-Rupp
GRC
$2.06B
| $246K | ﹤0.01% |
+9,468
| New | +$236K |
|
3078
Lincoln Electric
LECO
$15.4B
| $246K | ﹤0.01% |
+4,200
| New | +$229K |
|
|
VTAE
3079
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
| $245K | ﹤0.01% |
36,926
-166,536
| -82% | -$1.51M |
|
|
HTLF
3080
DELISTED
Heartland Financial USA, Inc.
HTLF
| $244K | ﹤0.01% |
+7,923
| New | +$236K |
|
|
NVDQ
3081
DELISTED
Novadaq Technologies Inc.
NVDQ
| $244K | ﹤0.01% |
+21,991
| New | +$233K |
|
|
HNR
3082
DELISTED
Harvest Natural Resources
HNR
| $244K | ﹤0.01% |
101,028
-3,925
| -4% | -$8.66K |
|
3083
Rocket Pharmaceuticals
RCKT
$388M
| $243K | ﹤0.01% |
8,211
+4,550
| +124% | +$137K |
|
|
SPWR
3084
DELISTED
SunPower Corporation Common Stock
SPWR
| $240K | ﹤0.01% |
16,427
+616
| +4% | +$9.57K |
|
3085
CALL
O-I Glass
OI
$1.11B
| $239K | ﹤0.01% |
+15,000
| New | +$215K |
|
3086
PUT
Wheaton Precious Metals
WPM
$72.8B
| $239K | ﹤0.01% |
14,400
-448,200
| -97% | -$6.49M |
|
|
BITA
3087
DELISTED
Bitauto Holdings Limited
BITA
| $239K | ﹤0.01% |
9,656
+401
| +4% | +$8.83K |
|
|
EXAM
3088
DELISTED
EXAMWORKS GROUP INC COM STK (DE)
EXAM
| $239K | ﹤0.01% |
8,095
-26,504
| -77% | -$720K |
|
|
CYTR
3089
DELISTED
CytRx Corp
CYTR
| $239K | ﹤0.01% |
14,833
+6,424
| +76% | +$87.8K |
|
3090
Henry Schein
HSIC
$9.98B
| $238K | ﹤0.01% |
3,509
-40,779
| -92% | -$2.55M |
|
3091
Phibro Animal Health
PAHC
$1.43B
| $238K | ﹤0.01% |
8,796
-4,884
| -36% | -$140K |
|
|
RAVN
3092
DELISTED
Raven Industries Inc
RAVN
| $237K | ﹤0.01% |
+14,808
| New | +$224K |
|
3093
CarMax
KMX
$8.91B
| $235K | ﹤0.01% |
+4,600
| New | +$217K |
|
3094
Lumen
LUMN
$5.85B
| $235K | ﹤0.01% |
7,347
-59,834
| -89% | -$1.68M |
|
3095
American Water Works
AWK
$27.8B
| $234K | ﹤0.01% |
3,400
-2,349
| -41% | -$153K |
|
|
MFLX
3096
DELISTED
MULTI-FINELINE ELECTRONIX INC
MFLX
| $234K | ﹤0.01% |
10,092
-5,414
| -35% | -$109K |
|
|
PFSW
3097
DELISTED
PFSweb, Inc.
PFSW
| $234K | ﹤0.01% |
17,807
+1,800
| +11% | +$22.3K |
|
3098
CubeSmart
CUBE
$9.21B
| $233K | ﹤0.01% |
+6,984
| New | +$215K |
|
3099
LG Display
LPL
$3.29B
| $233K | ﹤0.01% |
20,391
-5,465
| -21% | -$52.9K |
|
|
EXK
3100
Endeavour Silver
EXK
$3.19B
| $232K | ﹤0.01% |
94,123
+46,530
| +98% | +$81.4K |
|
Similar funds
David Shaw's Q1 2016 Portfolio in Review
As of Q1 2016, David Shaw held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
Against the trend, David Shaw opened a new position in EQT Corp worth $47.6M.
- David Shaw's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
- David Shaw added most to Allergan plc in Q1 2016, an estimated $397M increase.
- David Shaw's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
- David Shaw fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
- David Shaw's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
- David Shaw opened 382 new positions and closed 773 in Q1 2016.
- David Shaw's portfolio value fell 17% quarter-over-quarter to $55.7B.
Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.